Jason T. Huse

Active 2000–2025

Also published as
Jason T Huse
127
Papers
29,391
Citations
78
h-index
122
i10-index

Citations

Citations per year for Jason T. Huse1983: 1 citations1986: 1 citations1990: 1 citations1992: 1 citations1993: 1 citations1994: 3 citations2001: 14 citations2002: 14 citations2003: 21 citations2004: 18 citations2005: 14 citations2006: 18 citations2007: 20 citations2008: 14 citations2009: 22 citations2010: 86 citations2011: 129 citations2012: 216 citations2013: 247 citations2014: 322 citations2015: 391 citations2016: 416 citations2017: 589 citations2018: 486 citations2019: 1,313 citations2020: 1,550 citations2021: 1,698 citations2022: 1,349 citations2023: 1,148 citations2024: 1,504 citations2025: 852 citations2026: 52 citations1984–1985: no citations, so these years are not shown1987–1989: no citations, so these years are not shown1991: no citations, so this year is not shown1995–2000: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,519 citing papers, 29.1% of this breakdownChina: 2,508 citing papers, 16.1% of this breakdownGermany: 987 citing papers, 6.4% of this breakdownUnited Kingdom: 733 citing papers, 4.7% of this breakdownItaly: 646 citing papers, 4.2% of this breakdownCanada: 495 citing papers, 3.2% of this breakdownFrance: 488 citing papers, 3.1% of this breakdownNetherlands: 409 citing papers, 2.6% of this breakdownSwitzerland: 390 citing papers, 2.5% of this breakdownJapan: 390 citing papers, 2.5% of this breakdownSpain: 346 citing papers, 2.2% of this breakdownAustralia: 325 citing papers, 2.1% of this breakdown
0%29.1%Other 21.3%

Fields

  • Medicine51%
  • Biochemistry, Genetics and Molecular Biology31.4%
  • Immunology and Microbiology10.4%
  • Neuroscience3.7%
  • Engineering1.3%
  • Computer Science0.7%
  • Other1.5%

Topics

  • Glioma Diagnosis and Treatment12.2%
  • Immune cells in cancer5.5%
  • Epigenetics and DNA Methylation3.2%
  • Cancer Immunotherapy and Biomarkers2.9%
  • MicroRNA in disease regulation2.8%
  • Brain Metastases and Treatment2.7%
  • Other70.7%

Coauthors

All papers

Open in search
  1. CSF-1R inhibition alters macrophage polarization and blocks glioma progression

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Medicine 2013 cited by 2,474

  2. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jill S. Barnholtz‐Sloan, Siyuan Zheng, Kenneth R. Hess, Ganesh Rao, Matthew Meyerson, Rameen Beroukhim, Lee Cooper, Rehan Akbani, Margaret Wrensch, David Haussler, Kenneth D. Aldape, Peter W. Laird, David H. Gutmann, Houtan Noushmehr, Antonio Iavarone, Roel G.W. Verhaak, Samreen Anjum, Harindra Arachchi, J. Todd Auman, Miruna Balasundaram, Saianand Balu, Gene H. Barnett, Stephen Baylin, Sue Bell, Christopher C. Benz, Natalie Bir, Keith L. Black, Tom Bodenheimer, Lori Boice, Moiz S. Bootwalla, Jay Bowen, Christopher A. Bristow, Yaron S.N. Butterfield, Qingrong Chen, Lynda Chin, Juok Cho, Eric Chuah, Sudha Chudamani, Simon G. Coetzee, Mark L. Cohen, Howard Colman, Marta Couce, Fulvio D’Angelo, Tanja M. Davidsen, Amy Davis, John A. Demchok, Karen Devine, Li Ding, Rebecca Duell, J. Bradley Elder, Jennifer Eschbacher, Ashley Fehrenbach, Martin L. Ferguson, Scott Frazer, Gregory N. Fuller, Jordonna Fulop, Stacey Gabriel, Luciano Garofano, Julie M. Gastier-Foster, Nils Gehlenborg, Mark Gerken, Gad Getz, Caterina Giannini, William J. Gibson, Angela Hadjipanayis, D. Neil Hayes, David I. Heiman, Beth Hermes, Joe Hilty, Katherine A. Hoadley and 108 more - Cell 2016 cited by 2,375

  3. Glioma progression is shaped by genetic evolution and microenvironment interactions

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Spyridon Bakas, Annette T. Byrne, Fulvio D’Angelo, Hui K. Gan, Mustafa Khasraw, Simona Migliozzi, D. Ryan Ormond, Sun Ha Paek, Erwin G. Van Meir, Annemiek Walenkamp, Colin Watts, Tobias Weiss, Michael Weller, Karolina Palucka, Lucy F. Stead, Laila Poisson, Houtan Noushmehr, Antonio Iavarone, Roel G.W. Verhaak, Frederick S. Varn, Kevin C. Johnson, Jan Martinek, Jason T. Huse, MacLean P. Nasrallah, Pieter Wesseling, Lee Cooper, Tathiane M. Malta, Taylor Wade, Thaís S. Sabedot, Daniel J. Brat, Peter V. Gould, Adelheid Wöehrer, Kenneth Aldape, Azzam Ismail, Santhosh Sivajothi, Floris P Barthel, Hoon Kim, Emre Kocakavuk, Nazia Ahmed, Kieron White, Indrani Datta, Hyo-Eun Moon, Steven Pollock, Christine N. Goldfarb, Ga-Hyun Lee, Luciano Garofano, Kevin Anderson, Djamel Nehar-Belaid, Jill S. Barnholtz‐Sloan, Spyridon Bakas, Annette T. Byrne, Fulvio D’Angelo, Hui K. Gan, Mustafa Khasraw, Simona Migliozzi, D. Ryan Ormond, Sun Ha Paek, Erwin G. Van Meir, Annemiek Walenkamp, Colin Watts, Tobias Weiss, Michael Weller, Kristin Alfaro-Munoz, Samirkumar B. Amin, David M. Ashley, Christoph Bock, Andrew Brodbelt, Ketan R. Bulsara, Ana Valéria Castro, Jennifer Connelly and 47 more - Cell 2022 cited by 519

  4. Longitudinal molecular trajectories of diffuse glioma in adults

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Fletcher, Pim J. French, Hui K. Gan, Mark R. Gilbert, Peter V. Gould, Matthew Grimmer, Antonio Iavarone, Azzam Ismail, Michael D. Jenkinson, Mustafa Khasraw, Hoon Kim, Mathilde C. M. Kouwenhoven, Peter S. LaViolette, Meihong Li, Peter Lichter, Keith L. Ligon, Allison K. Lowman, Tathiane M. Malta, Tali Mazor, Kerrie L. McDonald, Annette M. Molinaro, Do-Hyun Nam, Naema Nayyar, Ho‐Keung Ng, Chew Yee Ngan, Simone P. Niclou, Johanna M. Niers, Houtan Noushmehr, Javad Noorbakhsh, D. Ryan Ormond, Chul‐Kee Park, Laila Poisson, Raúl Rabadán, Bernhard Radlwimmer, Ganesh Rao, Guido Reifenberger, K. Jason, Michael Schuster, Brian Shaw, Susan Short, Peter A. Sillevis Smitt, Andrew E. Sloan, Marion Smits, Hiromichi Suzuki, Ghazaleh Tabatabai, Erwin G. Van Meir, Colin Watts, Michael Weller, Pieter Wesseling, Bart A. Westerman, Georg Widhalm, Adelheid Woehrer, W. K. Alfred Yung, Gelareh Zadeh, Jason T. Huse, John de Groot, Lucy F. Stead, Roel G.W. Verhaak, Floris P Barthel, Kevin C. Johnson, Frederick S. Varn, Anzhela D. Moskalik, Georgette Tanner, Emre Kocakavuk, Kevin J. Anderson, Kenneth Aldape, Kristin Alfaro-Munoz, Samirkumar B. Amin, David M. Ashley, Pratiti Bandopadhayay and 63 more - Nature, Nat. 2019 cited by 609

  5. Glioma Groups Based on 1p/19q,IDH, andTERTPromoter Mutations in Tumors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Susan M. Chang, Michael D. Prados, Joseph L. Wiemels, John K. Wiencke, Margaret Wrensch, Robert B. Jenkins - New England Journal of Medicine 2015 cited by 1,984

  6. The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas

    Authors: , , , , , , , , - Science 2016 cited by 669

  7. Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study

    Authors: , , , , , , , , , , , , , , , , , - Neuro-Oncology 2015 cited by 580

  8. YTHDF3 Induces the Translation of m6A-Enriched Gene Transcripts to Promote Breast Cancer Brain Metastasis

    Authors: , , , , , , , , , , , , , , , , - Cancer Cell 2020 cited by 438

  9. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype

    Authors: , , , , , , , , , , , , , , , , , , , - Nature 2012 cited by 2,014

  10. Dynamic changes in glioma macrophage populations after radiotherapy reveal CSF-1R inhibition as a strategy to overcome resistance

    Authors: , , , , , , , , , , , , , - Science Translational Medicine 2020 cited by 322

  11. Serpins Promote Cancer Cell Survival and Vascular Co-Option in Brain Metastasis

    Authors: , , , , , , , , , , - Cell 2014 cited by 896

  12. Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2018 cited by 404

  13. Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Clark C. Chen, Changiz Geula, Raghu Kalluri, Tomasz Żal, Amy B. Heimberger - OncoImmunology 2017 cited by 365

  14. Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jianjun Zhang, Sheri L. Holmen, Michael T. Tetzlaff, Michael A. Davies - Cancer Discovery 2019 cited by 347

  15. Osteopontin-CD44 Signaling in the Glioma Perivascular Niche Enhances Cancer Stem Cell Phenotypes and Promotes Aggressive Tumor Growth

    Authors: , , , , , , , , , - Cell stem cell 2014 cited by 549

  16. Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Neuro-Oncology 2019 cited by 166

  17. High throughput single cell long-read sequencing analyses of same-cell genotypes and phenotypes in human tumors

    Authors: , , , , , , , , , , , - Nature Communications 2023 cited by 86

  18. OncoTree: A Cancer Classification System for Precision Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sarah P. Suehnholz, Moriah H. Nissan, Gopa Iyer, Rajmohan Murali, Nancy Bouvier, Robert A. Soslow, David M. Hyman, Anas Younes, Andrew M. Intlekofer, James J. Harding, Richard D. Carvajal, Paul Sabbatini, Ghassan K. Abou‐Alfa, Luc G.T. Morris, Yelena Y. Janjigian, Meighan M. Gallagher, Tara A. Soumerai, Ingo K. Mellinghoff, A. Ari Hakimi, Matthew G. Fury, Jason T. Huse, Aditya Bagrodia, Meera Hameed, Stacy B. Thomas, Stuart M. Gardos, Ethan Cerami, Tali Mazor, Priti Kumari, Pichai Raman, Priyanka Shivdasani, Suzanne P. MacFarland, Scott Newman, Angela J. Waanders, Jianjiong Gao, David B. Solit, Nikolaus Schultz - JCO Clinical Cancer Informatics 2021 cited by 150

  19. Classification of adult‐type diffuse gliomas: Impact of the World Health Organization 2021 update

    Authors: , - Brain Pathology 2022 cited by 152

  20. Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response

    Authors: , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2012 cited by 542

  21. Mutant-IDH1-dependent chromatin state reprogramming, reversibility, and persistence

    Authors: , , , , , , , , , , , , , , , , , - Nature Genetics 2017 cited by 231

  22. Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy

    Authors: , , , , , , , , , , , - Neuro-Oncology 2017 cited by 428

  23. Most Human Non-GCIMP Glioblastoma Subtypes Evolve from a Common Proneural-like Precursor Glioma

    Authors: , , , , , , , , - Cancer Cell 2014 cited by 392

  24. Blocking immunosuppressive neutrophils deters pY696-EZH2–driven brain metastases

    Authors: , , , , , , , , , , , , , , , , - Science Translational Medicine 2020 cited by 119